Polyrizon Ltd Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $0TTM through 31 Dec 2025
Net Income -$3.3MTTM through 31 Dec 2025
Free Cash Flow -$4.5MTTM through 31 Dec 2025
Margins
| Current |
|---|
Returns
-25.4%ROE
-24.7%ROA
Balance Sheet Health
Debt / Equity0.00x
Current Ratio29.03x
Net Debt-$12.5Mnet cash position
Cash & Equivalents$1.3M
Quality Metrics
Altman Z-Score33.87
Piotroski F-Score1 / 9
Multi-Year Trend
Diluted EPS-$4.90TTMFY2025: $4.90
Dividend
No dividend
Capital Allocation
R&D Spend$2.1M
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.